136 related articles for article (PubMed ID: 35667035)
1. Expression of tumour transcription factor GLI1 in canine mammary tumours tissue.
Liu P; Lu Y; Yang Y; Chen X; Xiong W; Sun J
Vet Med Sci; 2022 Jul; 8(4):1451-1457. PubMed ID: 35667035
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis.
Riku M; Inaguma S; Ito H; Tsunoda T; Ikeda H; Kasai K
Oncotarget; 2016 Feb; 7(5):5690-701. PubMed ID: 26744317
[TBL] [Abstract][Full Text] [Related]
3. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
4. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
5. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS
Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817
[TBL] [Abstract][Full Text] [Related]
7. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Shahi MH; Farheen S; Mariyath MP; Castresana JS
Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
[TBL] [Abstract][Full Text] [Related]
8. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH
Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162
[TBL] [Abstract][Full Text] [Related]
9. Elevated Krüppel-like factor 4 transcription factor in canine mammary carcinoma.
Chu PY; Hsu NC; Liao AT; Yeh KT; Hou MF; Liu CH
BMC Vet Res; 2011 Oct; 7():58. PubMed ID: 21978458
[TBL] [Abstract][Full Text] [Related]
10. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma.
Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y
Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964
[TBL] [Abstract][Full Text] [Related]
11. Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.
Sakai K; Yonezawa T; Yamawaki H; Oyamada T
J Vet Med Sci; 2015 Oct; 77(10):1319-22. PubMed ID: 25985817
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein expression in canine malignant mammary tumours.
Romanucci M; Marinelli A; Sarli G; Della Salda L
BMC Cancer; 2006 Jun; 6():171. PubMed ID: 16803633
[TBL] [Abstract][Full Text] [Related]
13. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
[TBL] [Abstract][Full Text] [Related]
15. [SOX2-OT/SOX2 axis regulates lung cancer H520 cell migration
Dong H; Zeng L; Wu Y; Miao S; Ni N; Liu N; Chen W; DU J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1431-1439. PubMed ID: 36329576
[TBL] [Abstract][Full Text] [Related]
16. The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer.
Jia Y; Gu D; Wan J; Yu B; Zhang X; Chiorean EG; Wang Y; Xie J
Oncogene; 2019 Mar; 38(10):1764-1777. PubMed ID: 30382189
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study.
Terzaghi L; Banco B; Groppetti D; Dall'Acqua PC; Giudice C; Pecile A; Grieco V; Lodde V; Luciano AM
Res Vet Sci; 2020 Oct; 132():101-107. PubMed ID: 32544632
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
19. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
20. Expression of endothelin-1 and endothelin-1 receptor A in canine mammary tumours.
Restucci B; Martano M; Maiolino P
Res Vet Sci; 2015 Jun; 100():182-8. PubMed ID: 25816929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
